Biogen's promising Alzheimer's drug advances to Phase 3 trial

March 23, 2015 8:06 AM

24 4

Over the last 5 years or so researchers have made tantalizing progress against the scourge of Alzheimer's disease, but the developments have yet to get to the final phase of testing.

Then suddenly last week a drug from pharmaceutical giant Biogen Idec grabbed the attention of the scientific world. It also got the attention of a perhaps harder-to-impress group – Wall Street traders. Biogen stock surge nearly 10% in a single day.

Read more

To category page